Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 1

Clinical and hemodynamic features of Eisenmenger syndrome patients at the time of first admission: A tertiary referral-center experience

Eisenmenger sendromlu hastaların ilk başvuru anındaki klinik ve hemodinamik özellikleri: Tersiyer merkez deneyimi

Pages
11–15
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this cases exercise capacity is restricted and this restriction is reflected in laboratory parameters. (Anadolu Kardiyol Derg 2012; 12: 11-5)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, patients admitted with the diagnosis of Eisenmenger syndrome (ES) in a tertiary referral center were analyzed.
📊
Key Findings & Data:Methods: The data of 20 consecutive patients (mean age: 27.6+1.8 years, 7 male and mean follow-up time: 35.6±9.1 months) with ES were retrospectively analyzed.
💡
Conclusion & Impact:In this cases exercise capacity is restricted and this restriction is reflected in laboratory parameters. (Anadolu Kardiyol Derg 2012; 12: 11-5)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, patients admitted with the diagnosis of Eisenmenger syndrome (ES) in a tertiary referral center were analyzed. Methods: The data of 20 consecutive patients (mean age: 27.6+1.8 years, 7 male and mean follow-up time: 35.6±9.1 months) with ES were retrospectively analyzed. Demographic characteristics, symptoms, physical examination, laboratory and hemodynamic parameters were analyzed at the time of first admission. Results: The most frequent underlying heart diseases were ventricular septal defect (VSD) with complex congenital disease (n:8, 40%) and isolated VSD (n:7, 35%). 6-minute walking test distance was 347.9±33.7 meters and 15 patients (75%) had a functional capacity of NYHA Class III, at the time of admission. ES was diagnosed with catheterization in all patients and mean systolic pulmonary arterial pressure measured by catheterization was 112±6.8 mmHg. Pulmonary function tests, FVC (forced vital capacity), FEV1 (forced expiratory volume), FEV1/FVC values were respectively, 3.1±0.4, 2.5±0.4 L and 76.7±3.3%. Metabolic tests were performed in all patients at the first visit. Mean VO2 max was 16.7 ±1.0 ml / kg/min and VE/VCO2 rate was 53.9±3.2%. Although PH and partial pressure of carbon dioxide levels were within normal range in blood gas analysis, oxygen saturation and partial pressure of oxygen levels were low. Conclusion: The most common underlying heart disease of ES patients is VSD. In this cases exercise capacity is restricted and this restriction is reflected in laboratory parameters. (Anadolu Kardiyol Derg 2012; 12: 11-5)

Özet

Amaç: Bu çalışmada tersiyer bir merkeze Eisenmenger sendromu (ES) tanısı ile başvuran olgular incelenmiştir. Yöntemler: Eisenmenger sendromu tanılı 20 olgunun verileri (ortalama yaş: 27.6+1.8 yıl, 7’si erkek) retrospektif olarak incelendi. Takibe başlandığı andaki demografik özellikleri, semptomları, fizik muayene, laboratuvar ve hemodinamik bulguları değerlendirildi. Bulgular: Kompleks konjenital bozukluk ile beraber görülen ventriküler septal defekt (VSD) (n=8, %40) ile izole VSD (n=7, %35) en sık altta yatan kalp hastalığı idi. İlk başvuru anındaki 6 dakika yürüme testi (6DYT) mesafesi 347.9±33.7 metre ve %75’i NYHA fonksiyonel sınıf 3 kapasiteye sahipti. Olguların hepsinde ES tanısı kateterizasyon ile konulmuştu ve kateter ile ölçülen ortalama sistolik pulmoner arteriyel basınç değeri 112.0±6.8 mmHg idi. Solunum fonksiyon testlerinden FVC (zorlu vital kapasite), FEV1 (zorlu ekspiratuvar hacim) ve FEV1/FVC değerleri sırasıyla 3.1±0.4, 2.5±0.4 L ve %76.7±3.3 idi. Bütün hastalara takibe başlandığı anda metabolik test yapıldı. VO2 max miktarı 16.7±1.0 ml/kg/dk ve VE/VCO2 oranı %53.9±3.2 idi. Kan gazı analizinde ise PH ve parsiyel karbondioksit basıncı normal sınırlarda olmasına rağmen oksijen satürasyonu ve parsiyel oksijen basıncı düzeyleri düşük idi. Sonuç: Eisenmenger sendromlu hastalarda en sık konjenital hastalık VSD’dir. Bu olgularda egzersiz kapasitesi kısıtlanmıştır ve bu kısıtlanma laboratuvar parametrelerine yansımaktadır. (Anadolu Kardiyol Derg 2012; 12: 11-5)

🔖

Cite This Article

DEMİR, E., NALBANTGİL, S., YAĞDI, T., ÖZBARAN, M., ENGİN, Ç., ATAY, Y., GÜNGÖR, H., ERTUGAY, S., AYIK, M. F. (2022). Clinical and hemodynamic features of Eisenmenger syndrome patients at the time of first admission: A tertiary referral-center experience. Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 1, 11–15. https://ajindex.com/articles/436384

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Kidd L, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, O’Fallon WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 1993; 87: 38-51
  2. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive diseaselong- term follow-up and prediction of outcome after surgical correction. Circulation 1987; 76: 1037-42. [CrosRef] 3. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005; 112: 828-35. [CrosRef] 4. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039-50. [CrosRef] 5. Beghetti M, Galiè N. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Card 2009; 53: 733-40. [CrosRef] 6. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958; 2: 755-62. [CrosRef] 7. Gault JH, Morrow AG, Gay WA Jr, Ross J. Atrial septal defect in patients over the age of forty years: clinical and hemodynamic studies and the effects of operation. Circulation 1968; 37: 261-72
  3. Semizel E, Alehan D, Özer S, Serdar MA. Eisenmenger syndrome: identifying the clues for arrhythmia. Anadolu Kardiyol Derg 2008; 8: 32-7
  4. Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006; 27: 1737-42. [CrosRef] 10. Cantor WJ, Harrison DA, Moussadji JS, Connelly MS, Webb GD, Liu P, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999; 84: 677-81. [CrosRef] 11. Somerville J. How to manage the Eisenmenger syndrome. Int J Cardiol 1998; 63: 1-8. [CrosRef] 12. Kumar RK, Sandoval J. Advanced pulmonary vascular disease: the Eisenmenger syndrome. Cardiol Young 2009; 19: 622-6. [CrosRef] 13. Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol 2000; 86: 1198-204. [CrosRef] 14. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med 1988; 109: 406-13
  5. Gidding SS, S